Aug 2026· Viruses· Vol 18, pp. 942· 0 citations· 58 references
Medicine
TL;DR
The isolation and characterisation of five novel lytic bacteriophages that specifically target K. grimontii are described and provides a basis for further evaluation of their potential in phage therapy.
Abstract
Klebsiella grimontii is an emerging pathogen associated with multidrug resistance. Although a single recent study reported phages against K. grimontii, their taxonomic diversity and structural characterisation remained limited. Here, we describe the isolation and characterisation of five novel lytic bacteriophages that specifically target K. grimontii strain K15g, originally isolated from a rotting iris rhizome. Phages Silvester, Lyra, Lyris, Mirion, and Helios were isolated from wastewater samples collected in the Moscow region and represent three distinct morphotypes: podovirus (Silvester), siphovirus (Lyra, Lyris, Mirion), and myovirus (Helios). Whole-genome sequencing revealed that Silvester belongs to the genus Przondovirus (family Autographiviridae); Lyra, Lyris, and Mirion are members of the genus Sugarlandvirus (family Demerecviridae); and Helios falls within the genus Slopekvirus (family Straboviridae). All five phages lack genes associated with lysogeny, virulence factors, or antibiotic resistance, indicating their suitability for therapeutic applications. Structural modelling of the receptor-binding proteins revealed diverse architectures of adsorption apparatuses, including a two-depolymerase complex in Silvester, T5-like tail fibres in the Sugarlandvirus phages, and a set of long and short fibres with a structured cell-puncturing device in Helios. This study presents five novel phages active against Klebsiella grimontii and provides a basis for further evaluation of their potential in phage therapy.
The emergence and spread of Gram-negative pathogens that are resistant to multiple antibiotic classes pose a global risk to public health. Among such pathogens, carbapenem-resistant strains of Klebsiella pneumoniae (CR-KP) are of concern due to their resistance to treatment by most antibiotics and the mobility of their...
D. Mora, Trisha Gryder, L. Lessor et al.· Viruses· 0 citations
During intensive rainbow trout farming operations conducted between 2021 and 2024 in the Karkamış and Keban Dam Lakes, ten Lactococcus garvieae isolates recovered from moribund fish were recovered and identified as a member of the family Siphoviridae.
Oğuzhan Kuzucu, Mikail Özcan· Journal of King Saud Univers...· 0 citations
The findings suggest that, while all three phages exhibit high environmental resilience, Phage P25 is the most promising candidate for further genomic safety validation, serving as a vital biological component in therapeutic phage cocktail formulations to manage XDR vibriosis in sustainable aquaculture.
Van-Thanh Vo, Thom Chi Nguyen, L. Bui et al.· Israeli Journal of Aquacultu...· 0 citations
Background Klebsiella pneumoniae is a key causative agent of multidrug resistant nosocomial infections. Bacteriophages offer a promising alternative treatment, but the diversity of Klebsiella species requires the characterisation of a broad range of phages, particularly the poorly characterised jumbo phages. Materials...
Isla Lloyd-Evans, M. Ford, Jed Hazzard et al.· bioRxiv· 0 citations
Findings highlight lysogeny module plasticity in closely related phages and position Cat, with its naturally occurring repressor deletion and potent lytic activity, as a promising candidate against drug-resistant tuberculosis.
M. Zaychikova, Maja Malakhova, S. Kuznetsova et al.· International Journal of Mol...· 0 citations
The present study provides the physicochemical and genomic characterization of three Escherichia bacteriophages (6phi8, 6phi10, and 6phi13) isolated from the commercial phage preparation “Sextaphag®”. For each bacteriophage, lytic activity against E. coli MG1655, as well as pH and thermal stability, were determined. Wh...
V. Kulyabin, A. Shadrin· BioTech· 0 citations
We use cookies to run the site and, with your consent, for analytics and to show ads.
See our Cookie Policy.